82 related articles for article (PubMed ID: 22306008)
1. Expression of human ABCB5 confers resistance to taxanes and anthracyclines.
Kawanobe T; Kogure S; Nakamura S; Sato M; Katayama K; Mitsuhashi J; Noguchi K; Sugimoto Y
Biochem Biophys Res Commun; 2012 Feb; 418(4):736-41. PubMed ID: 22306008
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of cellular glutathione levels in human ABCB5- and murine Abcb5-transfected cells.
Kondo S; Hongama K; Hanaya K; Yoshida R; Kawanobe T; Katayama K; Noguchi K; Sugimoto Y
BMC Pharmacol Toxicol; 2015 Dec; 16():37. PubMed ID: 26666373
[TBL] [Abstract][Full Text] [Related]
3. In vitro translation of a 2.3-kb splicing variant of the hamster pgp1 gene whose presence in transfectants is associated with decreased drug resistance.
Ma JF; Grant G; Staelens B; Howard DL; Melera PW
Cancer Chemother Pharmacol; 1999; 43(1):19-28. PubMed ID: 9923537
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.
Hopper-Borge E; Chen ZS; Shchaveleva I; Belinsky MG; Kruh GD
Cancer Res; 2004 Jul; 64(14):4927-30. PubMed ID: 15256465
[TBL] [Abstract][Full Text] [Related]
5. RPN2 gene confers docetaxel resistance in breast cancer.
Honma K; Iwao-Koizumi K; Takeshita F; Yamamoto Y; Yoshida T; Nishio K; Nagahara S; Kato K; Ochiya T
Nat Med; 2008 Sep; 14(9):939-48. PubMed ID: 18724378
[TBL] [Abstract][Full Text] [Related]
6. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Frank NY; Margaryan A; Huang Y; Schatton T; Waaga-Gasser AM; Gasser M; Sayegh MH; Sadee W; Frank MH
Cancer Res; 2005 May; 65(10):4320-33. PubMed ID: 15899824
[TBL] [Abstract][Full Text] [Related]
7. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
9. Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers.
Arai T; Miyoshi Y; Kim SJ; Akazawa K; Maruyama N; Taguchi T; Tamaki Y; Noguchi S
Eur J Surg Oncol; 2008 Jul; 34(7):734-8. PubMed ID: 17764884
[TBL] [Abstract][Full Text] [Related]
10. Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: an in vitro study.
Mok TS; Choi E; Yau D; Johri A; Yeo W; Chan AT; Wong C
Oncology; 2006; 71(3-4):292-6. PubMed ID: 17657173
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.
Keniya MV; Holmes AR; Niimi M; Lamping E; Gillet JP; Gottesman MM; Cannon RD
Mol Pharm; 2014 Oct; 11(10):3452-62. PubMed ID: 25115303
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
13. Taxoids: effective agents in anthracycline-resistant breast cancer.
Ravdin PM
Semin Oncol; 1995 Dec; 22(6 Suppl 13):29-34. PubMed ID: 8604450
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell.
Almquist KC; Loe DW; Hipfner DR; Mackie JE; Cole SP; Deeley RG
Cancer Res; 1995 Jan; 55(1):102-10. PubMed ID: 7805019
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of MDR1 in amrubicinol-resistant lung cancer cells.
Takakuwa O; Oguri T; Ozasa H; Uemura T; Kasai D; Miyazaki M; Maeno K; Sato S
Cancer Chemother Pharmacol; 2011 Sep; 68(3):669-76. PubMed ID: 21128075
[TBL] [Abstract][Full Text] [Related]
16. Drug transporters in breast cancer: response to anthracyclines and taxanes.
Kümler I; Stenvang J; Moreira J; Brünner N; Nielsen DL
Expert Rev Anticancer Ther; 2015; 15(9):1075-92. PubMed ID: 26313418
[TBL] [Abstract][Full Text] [Related]
17. ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro.
Oprea-Lager DE; Bijnsdorp IV; VAN Moorselaar RJ; VAN DEN Eertwegh AJ; Hoekstra OS; Geldof AA
Anticancer Res; 2013 Feb; 33(2):387-91. PubMed ID: 23393328
[TBL] [Abstract][Full Text] [Related]
18. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer.
Ravdin PM
Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-18-S10-21. PubMed ID: 9275002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
